Moreover, YM101 increased the density of tumor infiltrating CD8+ T cells, relative to vehicle (p < 0.01), anti-TGF-β (p < 0.01), anti-PD-L1 (p < 0.05) (Fig. 8e). This evidence concerns the gene CD8A and neoplasm.